Portola Pharmaceuticals
PTLA
#5561
Rank
NZ$2.47 B
Marketcap
NZ$31.60
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Portola Pharmaceuticals (PTLA)

Last known market cap: NZ$2.47 Billion

As of June 2026 Portola Pharmaceuticals has a market cap of NZ$2.47 Billion. This makes Portola Pharmaceuticals the world's 5561th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Portola Pharmaceuticals from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$2.22 B7.58%
2021NZ$2.07 B5.64%
2020NZ$1.96 B-29.02%
2019NZ$2.76 B42.53%
2018NZ$1.93 B-56.66%
2017NZ$4.47 B144.17%
2016NZ$1.83 B-56.76%
2015NZ$4.23 B140.36%
2014NZ$1.76 B37.48%
2013NZ$1.28 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$975.73 B 39,245.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$250.50 B 10,001.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$175.27 B 6,967.67%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$51.67 B 1,983.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$195.75 B 7,793.75%๐Ÿ‡บ๐Ÿ‡ธ USA